PIPE-505

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NamePIPE-505
Drug Alias NamePIPE-505
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAmyloid precursor protein secretases inhibitors
TargetsAmyloid precursor protein secretases
Therapy Area/IndicationsHearing Loss, Sensorineural
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesContineum Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesContineum Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHearing Loss, Sensorineural
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A